These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38211976)

  • 1. The CRISPR-Cas system in clinical strains of Acinetobacter baumannii: an in-silico analysis.
    Martínez-Trejo A; Ruiz-Ruiz JM; Gonzalez-Avila LU; Saldaña-Padilla A; Hernández-Cortez C; de Jesús Colmenero-Solís R; Bello-López JM; Castro-Escarpulli G
    Lett Appl Microbiol; 2024 Jan; 77(1):. PubMed ID: 38211976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pangenome of
    Mangas EL; Rubio A; Álvarez-Marín R; Labrador-Herrera G; Pachón J; Pachón-Ibáñez ME; Divina F; Pérez-Pulido AJ
    Microb Genom; 2019 Nov; 5(11):. PubMed ID: 31626589
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-cas subtype I-Fb in Acinetobacter baumannii: evolution and utilization for strain subtyping.
    Karah N; Samuelsen Ø; Zarrilli R; Sahl JW; Wai SN; Uhlin BE
    PLoS One; 2015; 10(2):e0118205. PubMed ID: 25706932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinformatic approach to identify confirmed and probable CRISPR-Cas systems in the
    Mancilla-Rojano J; Flores V; Cevallos MA; Ochoa SA; Parra-Flores J; Arellano-Galindo J; Xicohtencatl-Cortes J; Cruz-Córdova A
    Front Microbiol; 2024; 15():1335997. PubMed ID: 38655087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis reveals high virulence and antibiotic resistance amongst phage susceptible Acinetobacter baumannii.
    Leungtongkam U; Thummeepak R; Kitti T; Tasanapak K; Wongwigkarn J; Styles KM; Wellington EMH; Millard AD; Sagona AP; Sitthisak S
    Sci Rep; 2020 Sep; 10(1):16154. PubMed ID: 32999368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of the CRISPR/Cas System in
    Cruz-López EA; Rivera G; Cruz-Hernández MA; Martínez-Vázquez AV; Castro-Escarpulli G; Flores-Magallón R; Vázquez K; Cruz-Pulido WL; Bocanegra-García V
    Front Microbiol; 2021; 12():656996. PubMed ID: 34149645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Genome Analysis of
    Guo T; Yang J; Sun X; Wang Y; Yang L; Kong G; Jiao H; Bao G; Li G
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A
    Wu S; Xu R; Su M; Gao C; Liu Y; Chen Y; Luan G; Jia X; Wang R
    Microbiol Spectr; 2022 Oct; 10(5):e0195722. PubMed ID: 36047802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
    Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yadav G; Singh R
    Front Microbiol; 2022; 13():909886. PubMed ID: 36060733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms.
    Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas phage defense systems and prophages in Candidatus Accumulibacter.
    Deng X; Yuan J; Chen L; Chen H; Wei C; Nielsen PH; Wuertz S; Qiu G
    Water Res; 2023 May; 235():119906. PubMed ID: 37004306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems and diversity of targeting phages in Lactobacillus johnsonii strains; insights from genome mining approach.
    Nami Y; Rostampour M; Panahi B
    Infect Genet Evol; 2023 Oct; 114():105500. PubMed ID: 37703922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of CRISPR/Cas system in Clostridium perfringens.
    Long J; Xu Y; Ou L; Yang H; Xi Y; Chen S; Duan G
    Mol Genet Genomics; 2019 Oct; 294(5):1263-1275. PubMed ID: 31134321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Propionibacterium genomes: CRISPR-Cas systems, phage/plasmid diversity, and insertion sequences.
    Kahraman-Ilıkkan Ö
    Arch Microbiol; 2022 Jun; 204(7):434. PubMed ID: 35763226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous
    Wang Y; Yang J; Sun X; Li M; Zhang P; Zhu Z; Jiao H; Guo T; Li G
    Microbiol Spectr; 2022 Aug; 10(4):e0082922. PubMed ID: 35938813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation into the prevalent CRISPR-Cas systems among the Aeromonas genus.
    Baliga P; Shekar M; Tg P; Sk G
    J Basic Microbiol; 2021 Oct; 61(10):874-882. PubMed ID: 34486151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.